CYRAMZA

Welcome to the Brand page for “CYRAMZA”, which is offered here for The mark consists of literal element cyramza with arrow centered over the a and rounded arch over the arrow.;pharmaceutical preparations, pharmaceutical preparations for the treatment of alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, parkinson's disease, psychiatric disorders, sleep disorders; diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “CYRAMZA” is believed to be currently owned by “ImClone LLC”.


Owner:
IMCLONE LLC
Owner Details
Description:
The mark consists of literal element CYRAMZA with arrow centered over the A and rounded arch over the arrow.;Pharmaceutical preparations, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases;Color is not claimed as a feature of the mark.;
Categories: